Archives

XPOVIO® Now Funded in Saskatchewan

Sep 1, 2023

FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Saskatchewan as of September 1st. Please see the following link for full funding criteria: Drug Formulary (saskcancer.ca). We are excited about this important milestone for...

Accessibility by WAH

XPOVIO® Now Funded in Saskatchewan

Recent Posts

Recent Comments

Categories

Meta